Use of second generation supraglottic airway device for endovascular treatment of unruptured intracranial aneurysms: a retrospective cohort.

ABSTRACT:

Background

We aimed to assess the feasibility of using supraglottic devices as an alternative to orotracheal intubation for airway management during anesthesia for endovascular treatment of unruptured intracranial aneurisms in our department over a nine-year period.

Methods

Retrospective single center analysis of cases (2010-2018). Primary outcomes: airway management (supraglottic device repositioning, need for switch to orotracheal intubation, airway complications).

Secondary outcomes

aneurysm complexity, history of subarachnoid hemorrhage, hemodynamic monitoring, and perioperative complications.

Results

We included 187 patients in two groups: supraglottic device 130 (69.5%) and orotracheal intubation 57 (30.5%). No adverse incidents were recorded in 97% of th

SUBMITTER: Hurtado P 

PROVIDER: S-EPMC9373688 | biostudies-literature | 2021 Jul-Aug

REPOSITORIES: biostudies-literature